Comparing two hepatitis B vaccines for newborns
Part of Digestive system, Infections clinical trials.
This study tests whether two different hepatitis B vaccines can be used interchangeably for the first dose given at birth. It aims to ensure both vaccines protect newborns equally well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a healthy full-term newborn (born between 37 and 42 weeks of pregnancy)
- Your baby weighs between 2.5 and 4 kg (5.5 to 8.8 pounds) at birth
- A parent or legal guardian can review and sign a consent form
- The family agrees to follow the study schedule and instructions
- Your baby has no serious illness or fever (temperature less than 37.5°C) at the time of vaccination
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving the hepatitis B vaccine to full-term newborns who had multiple stomach or intestine surgeries is safe and works well. It aims to protect these babies from hepatitis B infection.
This study compares two ways to give hepatitis B treatment to pregnant women who have the virus, to see which works better at preventing the baby from getting hepatitis B. If you are in your first or second trimester, this might be an option for you.
This study tests a new hepatitis B vaccine to see if it is safe and helps the body fight the virus. It is for healthy people who have not had a hepatitis B vaccine in the last 10 years.
This study tests a new vaccine called BK1803 in healthy infants to see if it is safe and works well. It may help protect against several serious diseases.
This study tests antiviral medicine in babies under 1 year old who have hepatitis B. The goal is to see if early treatment can help clear the virus and protect the liver.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
Hear when a new Vaccination Adverse Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.